The Affordability of Guideline-Directed Medical Therapy
Alexander T. Sandhu, Paul A. Heidenreich
Abstract
Heart failure with reduced ejection fraction has seen remarkable advances with multiple medical therapies that reduce mortality. Despite these breakthroughs, guideline-recommended medical therapy (GDMT) is underutilized. The reasons for suboptimal implementation are manifold but surmountable. These include gaps in clinician knowledge, patient reluctance to take chronic medications, clinical inertia, and, increasingly, GDMT affordability.
Topics & Concepts
MedicineGuidelineIntensive care medicineMedical therapyInternal medicinePathologyMedication Adherence and CompliancePharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life